Pharmacocinétique de l'amikacine chez l'adulte : une hétérogénéité qui remet en cause le calcul de la dose basé sur le poids
Thérapie, 64 1 (2009) 47-53
Published online: 2009-05-26
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Is the subcutaneous route an alternative for administering ertapenem to older patients? PHACINERTA study
Claire Roubaud Baudron, Rachel Legeron, Julien Ollivier, et al.Journal of Antimicrobial Chemotherapy 74 (12) 3546 (2019)
https://doi.org/10.1093/jac/dkz385
Determinants of amikacin first peak concentration in critically ill patients
Clément Boidin, Sophie Jenck, Laurent Bourguignon, Sejad Torkmani, Aurore Roussey‐Jean, Stanislas Ledochowski, Lucie Marry, Nacim Ammenouche, Hervé Dupont, Frédéric Marçon, Bernard Allaouchiche, Julien Bohé, Alain Lepape, Sylvain Goutelle and Arnaud FriggeriFundamental & Clinical Pharmacology 32 (6) 669 (2018)
https://doi.org/10.1111/fcp.12374
Bayesian Network to Optimize the First Dose of Antibiotics: Application to Amikacin
Guillaume Debeurme, Michel Ducher, Elodie Jean-bart, Sylvain Goutelle and Laurent BourguignonInternational Journal of Pharmacokinetics 1 (1) 35 (2016)
https://doi.org/10.4155/ipk.16.3
Study of relationship between volume of distribution and body weight application to amikacin
L. Rughoo, L. Bourguignon, P. Maire and M. DucherEuropean Journal of Drug Metabolism and Pharmacokinetics 39 (2) 87 (2014)
https://doi.org/10.1007/s13318-013-0160-y
Calcul de la première dose d’amikacine : évaluation des recommandations posologiques actuelles
E. Jean-Bart, G. Debeurme, M. Ducher and L. BourguignonAnnales Pharmaceutiques Françaises 71 (1) 7 (2013)
https://doi.org/10.1016/j.pharma.2012.10.002
Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations
Jean‐Marie Conil, Bernard Georges, Stéphanie Ruiz, Thomas Rival, Thierry Seguin, Pierre Cougot, Olivier Fourcade, Georges Houin Pharmd and Sylvie SaivinBritish Journal of Clinical Pharmacology 71 (1) 61 (2011)
https://doi.org/10.1111/j.1365-2125.2010.03793.x
Actualités en antibiothérapie — Aminosides toujours et encore: bon usage et suivi thérapeutique
R. GauzitRéanimation 20 (S2) 290 (2011)
https://doi.org/10.1007/s13546-010-0106-1
Impact of infusion method on amikacin serum levels in humans
N. Simon, B. Décaudin, D. Lannoy, et al.Pulmonary Pharmacology & Therapeutics 23 (4) 324 (2010)
https://doi.org/10.1016/j.pupt.2010.03.005
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Fabio Silvio Taccone, Pierre-François Laterre, Herbert Spapen, Thierry Dugernier, Isabelle Delattre, Brice Layeux, Daniel De Backer, Xavier Wittebole, Pierre Wallemacq, Jean-Louis Vincent and Frédérique JacobsCritical Care 14 (2) (2010)
https://doi.org/10.1186/cc8945